Ascletis Announces ASC47 in Combination with Semaglutide Demonstrated Up to 56.2% Greater Relative Reduction in Body Weight in Participants with Obesity Compared to Semaglutide ...

Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") announces that ASC47, a muscle-preserving weight loss drug candidate, in combination with semaglutide, demonstrated up to 56.2% greater relative reduction ...

10 Selected BI Products: A Comprehensive Analysis of How Large and Small Enterprises Build and Apply BI Systems

Lingyang Quick BI is a full-scenario, data consumption-oriented BI product under Alibaba Cloud. Leveraging Alibaba's technological strength and rich data processing experience, it aims to help ...
Investing.com UK

FTSE 100 Live: London stocks climb as Fed cut, BoE holds and UK-US pact signed

The FTSE 100 added 0.2% or 19 points to close at 9,228, little changed after the Bank of England held rates steady. “Sterling ...

Josh Bersin Company Research Reveals How Talent Acquisition Is Being Revolutionized by AI

The Josh Bersin Company, the world's most trusted HR advisory firm, today released new research showing that jobs aren't ...